Abstract
The expression of parathyroid hormone-related protein (PTHrP) at primary and metastatic sites was studied retrospectively in specimens obtained at operation and autopsy from 11 patients. The anti-human PTHrP monoclonal antibody, 4B3, was used in the immunohistochemical studies. The 11 cases showed metastases to the liver and the lung, and 9 showed bone metastases at autopsy. At primary sites, PTHrP was positive in the 9 cases with bone metastases, while the other 2 cases were negative for PTHrP. Regardless of the intensities of immunohistochemical staining of PTHrP at primary sites, cancer cells at metastatic sites in the liver and the lung were almost all negative for PTHrP. On the other hand, all PTHrP-positive cases at primary sites at operation showed skeletal metastases at autopsy, and the intensity of the immunohistochemical staining of PTHrP was strongly positive at all the sites of skeletal metastasis. These results suggest that while PTHrP is an important factor that causes cancer cells to erode and grow in skeletal bone, the expression of PTHrP is, concurrently, affected by an osseous microenvironment.
Similar content being viewed by others
Abbreviations
- HHM:
-
Humoral hypercalcemia of malignancy
- MoAb:
-
Monoclonal antibody
- PTH:
-
Parathyroid hormone
- PTHrP:
-
Parathyroid hormone-related protein
References
McDonnell GC, Dunstan CR, Evans R,et al; Quantitative bone histology in the hypercalcemia of malignant disease.J Clin Endocrinol Metab 55:1066–1072, 1982.
Fukumoto S, Matsumoto T, Watanabe T,et al: Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I -infected lymphocytes.Cancer Res 49:3849–3852, 1989.
Suva LJ, Winslow GA, Wettenhall REH,et al: A parathyroid hormone-related protein implicated in malignant hypercalcemia; Cloning and expression.Science 237:893–896, 1987.
Mangin M, Webb AC, Dreyer BE,et al: Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.Proc Natl Acad Sci USA 85:597–601, 1988.
Stewert AF, Wu T, Goumas D,et al: N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins; Identification of parathyroid hormone-like and parathyroid hormone -unlike domains.Biochem Biophys Res Commun 146:672–678, 1987.
Strewler GJ, Stern PH, Jacobs JW,et al: Parathyroid hormone-like protein from human renal carcinoma cells structural and functional homology with parathyroid hormone.J Clin Invest 80:1803–1807, 1987.
Southby J, Kissin MW, Danks JA,et al: Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.Cancer Res 50:7710- 7716, 1990.
Powell GJ, Southby J, Danks JA,et al: Localization of parathyroid hormone-related protein in breast cancer metastases; Increased incidence in bone compared with other sites.Cancer Res 51:3059–3061, 1991.
Kitazawa S, Fukase M, Kitazawa R,et al: Immunohistological evaluation of parathyroid hormonerelated protein in human lung cancer and normal tissue with newly developed monoclonal antibody.Cancer 67:984–989, 1991.
Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity.Nature 256:495–497, 1975.
Connerty HV, Briggs AR: Determination of serum calcium by means of orthocresolphthalein complexone.Am J Clin Path 45:290–296, 1966.
Payne RB, Little AJ, Williams RB,et al: Interpretation of serum calcium in patients with abnormal serum proteins.Brit Med 4:643, 1973.
Thomus AN, Loken HF, Gordan GS,et al. Hypercalcemia of metastatic breast cancer.Surg Forum 16:70 -71, 1960.
Mundy GR, Ibbotson KJ, D’Souza SM: Tumor products and the hypercalcemia of malignancy.J Clin Invest 76:391–394, 1985.
Galasko CSB: Mechanism of bone destruction in the development of skeletal metastses.Nature 263:507- 508, 1976.
Mansi JL, Berger U, Easton D,et al: Micrometastasis in bone marrow in patients with primary breast cancer; Evaluation as an early predictor of bone metastasis.Br Med J 295:1093–1096, 1987.
Benett A, Charlier EM, McDonald AM,et al: Prostagrandins and breast cancer.Lancet 24:624–626, 1977.
Derynck R, Goeddel DV, Ullrich A,et al: Synthesis of messenger RNAs for transforming growth factorsα andβ the epidermal growth factor receptor by human tumors.Cancer Res 47:707–712, 1987.
Kohno N, Kitazawa S, Fukase M, et al: The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases. Surgery Today 24, 1994, in press.
Rizzoli R, Bonjour JP: High extracellular calcium increases the production of parathyroid hormone-like activity by cultured Leydig tumor cells associated with humoral hypercalcemia.J Bone Min Res 4:839- 844, 1989.
Deftos LJ, Hogue-Angeletti R, Chalberg C,et al: PTHrP secretion is stimulated by CT and inhibited by CgA peptides.Endocrinology 125:563–565, 1989.
Henderson J, Sebag M, Rheim J,et al Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression.Cancer Res 51:6521–6528, 1991.
Kremer R, Karaplis AC, Henderson J,et al. Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes: Effect of growth factors and 1,25-dihydroxyvitamine D3on gene expression and secretion.J Clin Invest 122:884–893, 1991.
Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer; Long-term follow-up of the first patient cohort.Eur J Cancer 27:236–239, 1991.
Mansi JL, Easton D, Berger U,et al. Bone marrow micrometastases in primary breast cancer; Prognostic significance after 6 years’ follow-up.Eur J Cancer 27:1552–1555, 1991.
Author information
Authors and Affiliations
Additional information
Supported in part by Grant-in-Aid from Ministry of Education of Japan.
About this article
Cite this article
Kohno, N., Kitazawa, S., Sakoda, Y. et al. Parathyroid hormone-related protein in breast cancer tissues: Relationship between primary and metastatic sites. Breast Cancer 1, 43–49 (1994). https://doi.org/10.1007/BF02967374
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967374